Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

67
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
67
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

58
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
58
Dialysis01:27

Dialysis

272
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
272
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

1
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
1
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

394
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
394
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

346
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
346

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-Resolution Modeling of Wet Bulb Globe Temperature Reveals Substantial Heat Risks Across Crops and Work Shifts Among Agricultural Workers in Southern California.

GeoHealth·2026
Same author

Mind the Gap: eGFR Discordancy and Melphalan Toxicity in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant.

Kidney360·2026
Same author

High-salt and high-sucrose diets may not reliably induce hypertension or diabetes in rat models.

Scientific reports·2026
Same author

A 32-year species-specific live fuel moisture content dataset for southern California chaparral.

Scientific data·2026
Same author

Concordance of Prebiopsy and Postbiopsy Diagnosis in Hospitalized Patients with Acute Kidney Injury.

Kidney360·2026
Same author

Development of Urinalysis Screening Criteria for Rhabdomyolysis in Acute Kidney Injury.

Kidney360·2026

Related Experiment Video

Updated: Jun 9, 2025

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

4.4K

Early, Individualized Recommendations for Hospitalized Patients With Acute Kidney Injury: A Randomized Clinical

Abinet M Aklilu1,2, Steven Menez3, Megan L Baker2

  • 1Clinical and Translational Research Accelerator, Yale University, New Haven, Connecticut.

JAMA
|October 25, 2024
PubMed
Summary

Recommendations from a kidney action team did not significantly improve outcomes for hospitalized patients with acute kidney injury (AKI). While implementation rates were higher, the composite outcome of AKI progression, dialysis, or mortality remained unchanged.

More Related Videos

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

2.1K
Noninvasive and Invasive Renal Hypoxia Monitoring in a Porcine Model of Hemorrhagic Shock
07:48

Noninvasive and Invasive Renal Hypoxia Monitoring in a Porcine Model of Hemorrhagic Shock

Published on: October 28, 2022

1.1K

Related Experiment Videos

Last Updated: Jun 9, 2025

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

4.4K
Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

2.1K
Noninvasive and Invasive Renal Hypoxia Monitoring in a Porcine Model of Hemorrhagic Shock
07:48

Noninvasive and Invasive Renal Hypoxia Monitoring in a Porcine Model of Hemorrhagic Shock

Published on: October 28, 2022

1.1K

Area of Science:

  • Nephrology
  • Hospital Medicine
  • Clinical Informatics

Background:

  • Acute kidney injury (AKI) is a frequent and serious complication in hospitalized patients, often leading to adverse health events.
  • Early detection and intervention are crucial for managing AKI, but optimal strategies remain under investigation.

Purpose of the Study:

  • To determine if diagnostic and therapeutic recommendations from a kidney action team (KAT) delivered via electronic health record (EHR) improve outcomes for hospitalized patients with AKI compared to standard care.
  • To assess the impact of a KAT intervention on AKI progression, dialysis, and mortality.

Main Methods:

  • A randomized clinical trial involving 4003 hospitalized patients with AKI across 7 hospitals in the US.
  • Patients were randomized to either receive recommendations from a KAT via EHR or to usual care.
  • The KAT provided personalized recommendations within 1 hour of AKI detection, covering diagnostics, fluid management, electrolytes, acid-base balance, and medications.

Main Results:

  • The primary composite outcome (AKI progression, dialysis, or in-hospital mortality within 14 days) occurred in 19.8% of the intervention group and 18.4% of the usual care group (P=.28).
  • Implementation rates of KAT recommendations were significantly higher in the intervention group (33.8%) compared to the usual care group (24.3%).
  • No significant difference was observed in the primary composite outcome between the intervention and usual care groups.

Conclusions:

  • Despite higher implementation rates of recommendations, the kidney action team intervention did not significantly reduce the composite outcome of worsening AKI, dialysis, or mortality in hospitalized patients.
  • Further research may be needed to optimize KAT interventions or explore alternative strategies for improving AKI outcomes in the hospital setting.